🇺🇸 FDA
Pipeline program

DoriDuo, Mebocaína Anti-Inflam, 1.2 mg + 3 mg, comprimidos para chupar, Placebo to Test and Comparator

6630-9450-01

Phase 3 small_molecule active

Quick answer

DoriDuo, Mebocaína Anti-Inflam, 1.2 mg + 3 mg, comprimidos para chupar, Placebo to Test and Comparator for acute pharyngitis is a Phase 3 program (small_molecule) at Medice Arzneimittel Pütter GmbH & Co. KG with 1 ClinicalTrials.gov record(s).

Program details

Company
Medice Arzneimittel Pütter GmbH & Co. KG
Indication
acute pharyngitis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials